1. Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition
   Ae-Ran Choi et al, 2015, European Journal of Pharmacology CrossRef
2. Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition
   Dahea You et al, 2020, Drug Metabolism and Disposition CrossRef
3. Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation
   Cindy Q. Xia et al, 2012, Molecular Pharmacology CrossRef
4. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line
   Hong-Yu Duan et al, 2017, Chinese Medical Journal CrossRef
5. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine
   Ji Hyun Cheon et al, 2017, Biochemical and Biophysical Research Communications CrossRef
6. TRANSPORTERS AS THERAPEUTIC TARGETS IN HUMAN DISEASES
   Robert S. Jones et al, 2022, Drug Transporters CrossRef
7. Overview of the Classical Histone Deacetylase Enzymes and Histone Deacetylase Inhibitors
   Katherine Ververis et al, 2012, ISRN Cell Biology CrossRef
8. SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition
   Ju-Hwa Kim et al, 2014, European Journal of Pharmacology CrossRef
9. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition
   Ju-Hwa Kim et al, 2013, Biochemical and Biophysical Research Communications CrossRef
10. Epigenetic regulation of drug transporter expression in human tissues
    Takeshi Hirota et al, 2017, Expert Opinion on Drug Metabolism & Toxicology CrossRef
11. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat
    Kenneth Kin-Wah To et al, 2017, Lung Cancer CrossRef
12. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells
    Yunmoon Oh et al, 2022, International Journal of Molecular Sciences CrossRef
13. Selenium-doped calcium phosphate biomineral reverses multidrug resistance to enhance bone tumor chemotherapy
    Jianping Hu et al, 2021, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
14. HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)
    XUAN NI et al, 2015, Oncology Letters CrossRef
15. Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways
    Xue-Jie Jiang et al, 2012, Cancer Letters CrossRef
16. Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
    Jens Ceder et al, 2017, Frontiers in Oncology CrossRef
17. Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer
    Andrew J. Wilson et al, 2012, Gynecologic Oncology CrossRef
18. Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro
    Kyeong Seok Kim et al, 2020, Frontiers in Oncology CrossRef
19. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
    Pradhapsingh Bharathiraja et al, 2023, Drug Resistance Updates CrossRef
20. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy
    Haishan Zhao et al, 2016, Japanese Journal of Clinical Oncology CrossRef
21. Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
    Ivana Gojo et al, 2013, Clinical Cancer Research CrossRef
22. Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
    Céline Berthon et al, 2016, The Lancet Haematology CrossRef
23. Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo
    Ye Wei et al, 2018, Anti-Cancer Drugs CrossRef
24. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
    Zhaolin Chen et al, 2016, Cancer Letters CrossRef
25. Comprehension of the Relationship between Autophagy and Reactive Oxygen Species for Superior Cancer Therapy with Histone Deacetylase Inhibitors
    Yuka Ikeda et al, 2021, Oxygen CrossRef